Con Concord Biotech Limited at its board meeting held on May 23, 2024, the Board has recommended Dividend of INR 8.75 (@ 30%) per Equity Share of face value of INR 1 each fully paid up for the Financial Year 2023-24, subject to approval by shareholders of the Company at the upcoming AGM. Pursuant to the Regulation 42 of SEBI Listing Regulations, it is hereby informed that the Company has fixed 22nd June, 2024 as `Record Date' for the purpose of determining entitlement for the purpose of identifying the members entitlement to receive Dividend of INR 8.75 (@ 30%) per Equity Share having face value of INR 1/- each fully paid-up for the financial year 2023-24.